Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)]: Final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT

R. Gervais; A. Ducolone; T. Lechevalier; A. Legroumellec; E. Lemarie; E. Quoix; C. Le Pechoux; E. Bardet; M. Henry-Amar; J.-Y. Douillard

doi:10.1200/jco.2005.23.16_suppl.7016

Conventional radiation (RT) with daily carboplatin (Cb) compared to RT alone after induction chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)]: Final results of a randomized phase III trial in stage III unresectable non small cell lung (NSCLC) cancer. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7016 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7016-7016 ◽

Cited By ~ 14

Author(s):

R. Gervais ◽

A. Ducolone ◽

T. Lechevalier ◽

A. Legroumellec ◽

E. Lemarie ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Conventional Radiation

Download Full-text

Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group

European Journal of Cancer ◽

10.1016/j.ejca.2011.03.035 ◽

2011 ◽

Vol 47 (10) ◽

pp. 1546-1555 ◽

Cited By ~ 36

Author(s):

Andrea Koch ◽

Bengt Bergman ◽

Erik Holmberg ◽

Christer Sederholm ◽

Lars Ek ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Double Blind ◽

Phase Iii Trial ◽

Clinical Phase ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

Paclitaxel/carboplatin (PC) followed by twice daily chemoradiation (hfRT/PC) versus hfRT/PC followed by PC as induction to surgery in stage III non-small cell lung cancer (NSCLC): A randomized phase III trial of the Lung Cancer Study Group Mitteldeutschland

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.7541 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 7541-7541 ◽

Cited By ~ 1

Author(s):

R. Bonnet ◽

C. P. Schneider ◽

T. G. Wendt ◽

N. Presselt ◽

R. P. Baum ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

Phase III Trial of Gemcitabine Plus Carboplatin Versus Single-Agent Gemcitabine in the Treatment of Locally Advanced or Metastatic Non–Small-Cell Lung Cancer: The Swedish Lung Cancer Study Group

Yearbook of Oncology ◽

10.1016/s1040-1741(08)70416-0 ◽

2007 ◽

Vol 2007 ◽

pp. 198-203

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Single Agent ◽

Locally Advanced ◽

Small Cell ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

O-040 Randomized phase III trial for stage III unresectable nonsmall cell lung (NSCLC) cancer: Induction Chemotherapy (ICT) [vinorelbine (Vr)-cisplatine (P)] followed by conventional radiation (RT) without (arm A) or with daily carboplatin (Cb) (arm B). Final results. Study CRG/BMS/NPC/96 of the French Lung Cancer Study Group FNCLCC and IFCT

Lung Cancer ◽

10.1016/s0169-5002(05)80172-2 ◽

2005 ◽

Vol 49 ◽

pp. S16 ◽

Cited By ~ 2

Author(s):

J. Douillard ◽

R. Gervais ◽

E. Quoix ◽

T. Le Chevalier ◽

A. Le Groumellec ◽

...

Keyword(s):

Lung Cancer ◽

Induction Chemotherapy ◽

Phase Iii ◽

Study Group ◽

Phase Iii Trial ◽

Cancer Study ◽

Cancer Induction ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Conventional Radiation

Download Full-text

Gemcitabine versus gemcitabine/carboplatin in advanced non–small cell lung cancer: Preliminary findings in a phase III trial of the Swedish Lung Cancer Study Group

Seminars in Oncology ◽

10.1053/sonc.2002.34276 ◽

2002 ◽

Vol 29 (3) ◽

pp. 50-54 ◽

Cited By ~ 36

Author(s):

Christer Sederholm

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text

Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group

La radiologia medica ◽

10.1007/s11547-019-00999-w ◽

2019 ◽

Vol 124 (7) ◽

pp. 662-670 ◽

Cited By ~ 4

Author(s):

Paolo Borghetti ◽

Marco Lorenzo Bonù ◽

Rachele Giubbolini ◽

Niccolo’ Giaj Levra ◽

Rosario Mazzola ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Concomitant Radiotherapy

Download Full-text

O-097 A randomized phase III trial of six versus four cycles ofchemotherapy: Optimal duration of chemotherapy in advanced non-small-cell lung cancer: Korea cancer study group experience

Lung Cancer ◽

10.1016/s0169-5002(05)80231-4 ◽

2005 ◽

Vol 49 ◽

pp. S34-S35 ◽

Cited By ~ 2

Author(s):

J. Park ◽

S. Kim ◽

J. Jang ◽

E. Cho ◽

S. Yang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group ◽

Optimal Duration ◽

Group Experience

Download Full-text

Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: A phase III trial of the Southeastern Cancer Study Group

Lung Cancer ◽

10.1016/0169-5002(92)90074-t ◽

1992 ◽

Vol 8 (3-4) ◽

pp. 241

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Randomized Study ◽

Small Cell ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Phase Iii Trial ◽

Cancer Study Group

Download Full-text

A randomized phase III study of cisplatin and docetaxel with or without irinotecan in pts with advanced non-small cell lung cancer: Okayama Lung Cancer Study Group OLCSG 0403.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.7584 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7584-7584

Author(s):

K. Kiura ◽

M. Tabata ◽

N. Takigawa ◽

S. Kuyama ◽

Y. Segawa ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study Group ◽

Lung Cancer Study Group ◽

Phase Iii Study

Download Full-text

PD-065 Duration of chemotherapy in non-small-cell lung cancer: Multicenter, randomized, prospective clinical trial comparing 4 vs 6 cycles of carboplatin and gemcitabine. (Portuguese Lung Cancer Study Group 03/03)

Lung Cancer ◽

10.1016/s0169-5002(05)80398-8 ◽

2005 ◽

Vol 49 ◽

pp. S85

Author(s):

F. Barata ◽

B. Parente ◽

E. Teixeira ◽

F. Nogueira ◽

A. Fernandes ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Study Group ◽

Small Cell Lung ◽

Cancer Study ◽

Cancer Study Group ◽

Lung Cancer Study Group

Download Full-text